Grant: Operating Grant
University of British Columbia
$100,000.00
Investigations of nanoparticulate formulations of lipophilic prodrugs
FY 2008-09
Summary
Research in my laboratory has been focused on the development of lipid based drug delivery systems for use in the treatment of cancer. In this project we plan to synthesize lipophilic prodrugs of known drugs and encapsulate these compounds in micelle-like nanoparticles. We will be able to control the release of the prodrug from the nanoparticle by adjusting the size and nature of the lipid component of the prodrug. The physical and biological properties of the nanoparticles will be controlled by adjusting the formulation composition. This will allow us to optimize delivery of these drugs to tumor sites and potentially develop novel therapeutic treatments. This approach is particularly useful for drugs which are insoluble in water and which normally would be rapidly eliminated from the body.
Department
Program
Operating Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
183810
Name
Cullis Pieter R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
Investigations of nanoparticulate formulations of lipophilic prodrugs
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Drug Delivery; Nanoparticles; Polymer Stabilized Particles; Prodrugs
Abstract
Research in my laboratory has been focused on the development of lipid based drug delivery systems for use in the treatment of cancer. In this project we plan to synthesize lipophilic prodrugs of known drugs and encapsulate these compounds in micelle-like nanoparticles. We will be able to control the release of the prodrug from the nanoparticle by adjusting the size and nature of the lipid component of the prodrug. The physical and biological properties of the nanoparticles will be controlled by adjusting the formulation composition. This will allow us to optimize delivery of these drugs to tumor sites and potentially develop novel therapeutic treatments. This approach is particularly useful for drugs which are insoluble in water and which normally would be rapidly eliminated from the body.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cullis, Pieter R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~